638 results on '"LÄMMLE B"'
Search Results
2. OC 42.3 Immune-Mediated TTP Patients in Remission with Recovered ADAMTS13 Activity but an Open ADAMTS13 Conformation are at Risk for Earlier ADAMTS13 Relapse
3. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
4. The Von Willebrand factor multimer ratio and inflammatory markers in autoimmune thrombotic thrombocytopenic purpura
5. Neonatal exchange transfusion: hereditary thrombotic thrombocytopenic purpura (hTTP) should be in the differential diagnosis
6. Conclusion from 50 years of reports on prekallikrein or high-molecular-weight kininogen deficiency
7. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study
8. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
9. Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies
10. Komplexe Gerinnungsstörungen
11. P1528: GENETIC AND PHENOTYPIC CHARACTERIZATION OF HEREDITARY SPHEROCYTOSIS AND RELATED DISORDERS – DESCRIPTION OF 9 NEW GENETIC VARIANTS
12. Apoptosis In Sepsis And Multiple Organ Dysfunction Syndrome
13. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
14. Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism
15. Founder Effect of the Factor-IX-Propeptide-Val-10 Variant Is Responsible for Most Marcumar-lnduced Severe Haemophilia B Cases During Oral Anticoagulant Therapy — Consequences for Monitoring
16. Bedeutung der von-Willebrand-Faktor-spaltenden Protease in Diagnostik und klinischem Verlauf bei Patienten mit thrombotisch-thrombozytopenischer Purpura (TTP) und hämolytisch-urämischem Syndrom (HUS)
17. Venöse Thromboembolie in Schwangerschaft und Puerperium: Pathophysiologie, Therapie, Prophylaxe
18. Variability of anti‐PF4/heparin antibody results obtained by the rapid testing system ID‐H/PF4‐PaGIA
19. Hereditary afibrinogenemia - long-term observation of a highly thrombogenic condition and itʼs management: OR432
20. DNA in plasma indicates disease extent and predicts mortality in patients with venous thromboembolism: OR193
21. Hereditary TTP - a young patient population with high prevalence of arterial thromboembolic events: first results from the hereditary TTP registry: OR152
22. REDEFINING OUTCOMES IN IMMUNE TTP: AN INTERNATIONAL WORKING GROUP CONSENSUS REPORT
23. In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patientʼs hepatocytes
24. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)
25. Pregnancy Outcomes in Hereditary Thrombotic Thrombocytopenic Purpura – Room for (Further) Improvement.
26. ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock
27. International registry for patients with hereditary thrombotic thrombocytopenic purpura (TTP) - upshaw-Schulman syndrome: PA 4.19–1
28. Very early onset of autoimmune thrombotic thrombocytopenic purpura in five children with polynesian origin in four combined with immunodeficiency: OC 52.3
29. New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review
30. Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA
31. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
32. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA: reply to a rebuttal
33. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies
34. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods
35. A new tool to further explore the role of ADAMTS-13 in health and disease
36. Treatment of thrombotic thrombocytopenic purpura
37. Thrombotic thrombocytopenic purpura
38. More on: thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia
39. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
40. Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis
41. Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus
42. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease
43. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
44. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura
45. Accuracy of d-dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study
46. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia
47. Subcutaneous low-molecular-weight heparin for treatment of Trousseau’s syndrome
48. Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature
49. More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?
50. Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.